Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

New Drug Helps Huntington's Disease Afflicted Mice, Offspring

December 23, 2014 12:05 pm | News | Comments

Famine, drug abuse and even stress can “silence” certain genes, causing health problems in generations to come. Read more...                       


Drug Blocks Key Signal in Cancer Growth and Drug Resistance

December 23, 2014 8:46 am | by Institute of Cancer Research | News | Comments

An experimental cancer drug may block an important driver for the survival, growth and spread of cancer cells. Read more...                       


Vanda Regains U.S., Canadian Rights to Fanapt

December 23, 2014 8:30 am | News | Comments

Vanda Pharmaceuticals announced that it has reached a settlement agreement with Novartis related to the ongoing Fanapt license arbitration proceedings. Read more...                


Eli Lilly, University of Surrey Announce Diabetes Research Partnership

December 22, 2014 3:15 pm | News | Comments

Eli Lilly announced a five-year research partnership with the University of Surrey to study health outcomes, focusing on the effects of treatment in people with type 2 diabetes. Read more...            


High Vancomycin Doses Fuel Risk of Kidney Damage in Children

December 22, 2014 3:01 pm | by Johns Hopkins University | News | Comments

A new study shows that hospitalized children given high-dose IV infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney damage. Read more...          


AbbVie's Hepatitis C Treatment Gains FDA Approval

December 22, 2014 2:42 pm | by Linda A. Johnson - AP Business Writer | News | Comments

Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie. Read more...               


Mylan Launches First Generic Version of Menopause Treatment

December 22, 2014 12:57 pm | News | Comments

Mylan received final approval from the FDA for this product. Read more...                               


FDA Approves Cubist Antibiotic for Serious Infections

December 22, 2014 12:43 pm | by Linda A. Johnson - AP Business Writer | News | Comments

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract. Read more...                     


Juno Therapeutics Stock Surges in Market Debut

December 22, 2014 12:27 pm | by Associated Press | News | Comments

Amazon CEO Jeff Bezos is one of Juno's primary investors. Read more...                                 


Express Scripts, AbbVie Make Huge Hepatitis C Deal

December 22, 2014 12:18 pm | by Tom Murphy - AP Business Writer | News | Comments

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C. Read more...                    


North Korea May Soon Lift Ebola Restrictions

December 22, 2014 9:35 am | by Eric Talmadge - Associated Press | News | Comments

North Korea has been in virtual lockdown since October in order to prevent the disease from crossing its borders. Read more...                       


Research Suggests Riluzole May Prevent Foggy 'Old Age' Brain

December 22, 2014 9:26 am | by Rockefeller University | News | Comments

Researchers found they could stop normal, age-related memory loss in rats by treating them with riluzole. Read more...                        


Vitamin D Link to Short-Sightedness Ruled Out

December 22, 2014 9:10 am | by University of Bristol | News | Comments

New findings suggest that children with low levels of vitamin D in their blood are not at increased risk of developing myopia. Read more...                 


WHO: Recorded Ebola Deaths Top 7,000

December 22, 2014 8:54 am | by Boubacar Diallo - Associated Press | News | Comments

The worst Ebola outbreak on record has now killed more than 7,000 people. Read more...                             


Top 100 Talked-About Papers of 2014

December 19, 2014 5:06 pm | by Drug Discovery & Development Staff | News | Comments

The academic papers of 2014 most cited by news and social media covered an astonishing range of topics, from science fraud, to black holes, to time travelers, according to But at 45%, the most popular papers by far were in health and medicine. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.